Market Snapshot
  • BSE Sensex: 82634.48 0.08%
  • BSE 500: 36827.24 0.08%
  • BSE 200: 11484.12 0.06%
  • BSE 100: 26481.24 0.05%
  • BSE MidCap: 47033.02 0.10%
  • BSE SmallCap: 55475.4 0.28%
  • BSE BANKEX: 63913.48 0.22%
  • BSE IT: 37081.11 0.66%
  • Nifty 50: 25212.05 0.06%
  • Nifty 500: 23472.5 0.10%
  • Nifty 200: 14126.95 0.08%
  • Nifty 100: 25872.2 0.09%
  • Nifty Midcap 100: 59620.65 0.01%
  • Nifty Small 100: 19140.05 0.03%
  • Nifty IT: 37660.7 0.63%
  • Nifty PSU Bank: 7267.2 1.81%
News:
  • Tech Mahindra Q1 PAT drops 2% ...
  • PNC Infratech emerges as L-1 b...
  • Geojit Financial slumps as Q1 ...
  • Lupin launches Loteprednol Eta...
  • Godrej Properties acquires 50-...
  • Euro to INR:  100.29 -0.01%
  • Pound to INR:  115.62 -0.11%
  • Yen to INR:  0.58 0.06%
  • Dollar to INR:  85.89 0.08%
My Portfolio:
  • 0.00 0

Quotes

Back To Menu

Syncom Formulations (India) Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Invest

16 Jul 2025 | 03:59 PM

18.86
-0.05 (-0.26%)

  • Outperforms Index

    20.74%

    Return (1Y)

    Beaten BSE Healthcare by 5.42%

  • More Volatile

    3.51%

    Standard Deviation (1Y)

    Higher than BSE Healthcare by 2.46%

  • Not so consistent

    4/12

    Months

    underperformed BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

28

27.94

14

14.00

News & Announcements

  • Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter

    58 days ago

  • Syncom Formulations (India) schedules board meeting

    64 days ago

  • Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

    156 days ago

  • Syncom Formulations (India) schedules board meeting

    64 days ago

  • Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

    156 days ago

  • Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter

    247 days ago

  • Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter

    58 days ago

  • Syncom Formulations (India) schedules board meeting

    64 days ago

  • Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

    156 days ago

  • Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter

    247 days ago

  • Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter

    58 days ago

  • Syncom Formulations (India) schedules board meeting

    64 days ago

  • Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

    156 days ago

  • Syncom Formulations (India) schedules board meeting

    64 days ago

  • Syncom Formulations (India) consolidated net profit rises 85.71% in the December 2024 quarter

    156 days ago

  • Syncom Formulations (India) consolidated net profit rises 70.66% in the September 2024 quarter

    247 days ago

1
2
3
4
5
6
7
8
9
10
1
2
3
4
Price vs Volume

Stock Trivia

  • FII shareholding in Syncom Formulations (India) Ltd has decreased by -17.91% since past 3 Months

  • MF shareholding in Syncom Formulations (India) Ltd has increased by 157.14% since past 1 Year

  • FII shareholding in Syncom Formulations (India) Ltd has decreased by -17.91% since past 3 Months

  • FII shareholding in Syncom Formulations (India) Ltd has increased by 35.93% since past 1 Year

  • MF shareholding in Syncom Formulations (India) Ltd has increased by 157.14% since past 1 Year

  • FII shareholding in Syncom Formulations (India) Ltd has decreased by -17.91% since past 3 Months

  • MF shareholding in Syncom Formulations (India) Ltd has increased by 157.14% since past 1 Year

1
2
3
4
5
Prev
1
2
3
Prev
Loading...

Peer Comparison on Risk - Return

Loading...
Loading...